GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (MEX:IDXX) » Definitions » Cyclically Adjusted Price-to-FCF

IDEXX Laboratories (MEX:IDXX) Cyclically Adjusted Price-to-FCF : 107.87 (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2024-06-21), IDEXX Laboratories's current share price is MXN9320.00. IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was MXN86.40. IDEXX Laboratories's Cyclically Adjusted Price-to-FCF for today is 107.87.

The historical rank and industry rank for IDEXX Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:IDXX' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 54.86   Med: 102.01   Max: 212.8
Current: 96.25

During the past years, IDEXX Laboratories's highest Cyclically Adjusted Price-to-FCF was 212.80. The lowest was 54.86. And the median was 102.01.

MEX:IDXX's Cyclically Adjusted Price-to-FCF is ranked worse than
87.3% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 34.59 vs MEX:IDXX: 96.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IDEXX Laboratories's adjusted free cash flow per share data for the three months ended in Mar. 2024 was MXN33.271. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN86.40 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


IDEXX Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted Price-to-FCF Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.49 176.12 182.37 99.18 111.70

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.83 110.59 91.33 111.70 103.19

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted Price-to-FCF falls into.



IDEXX Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

IDEXX Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=9320.00/86.4
=107.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, IDEXX Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=33.271/131.7762*131.7762
=33.271

Current CPI (Mar. 2024) = 131.7762.

IDEXX Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 8.470 100.560 11.099
201409 10.146 100.428 13.313
201412 1.414 99.070 1.881
201503 -6.011 99.621 -7.951
201506 9.369 100.684 12.262
201509 10.241 100.392 13.443
201512 11.973 99.792 15.810
201603 0.963 100.470 1.263
201606 19.329 101.688 25.048
201609 18.718 101.861 24.215
201612 19.541 101.863 25.280
201703 1.596 102.862 2.045
201706 19.161 103.349 24.431
201709 19.226 104.136 24.329
201712 21.855 104.011 27.689
201803 2.282 105.290 2.856
201806 20.222 106.317 25.065
201809 16.705 106.507 20.668
201812 21.420 105.998 26.629
201903 -0.848 107.251 -1.042
201906 22.652 108.070 27.621
201909 21.380 108.329 26.007
201912 23.665 108.420 28.763
202003 -5.895 108.902 -7.133
202006 49.045 108.767 59.420
202009 44.252 109.815 53.102
202012 46.823 109.897 56.145
202103 24.519 111.754 28.912
202106 48.556 114.631 55.818
202109 33.795 115.734 38.479
202112 42.426 117.630 47.528
202203 16.957 121.301 18.421
202206 8.479 125.017 8.937
202209 36.186 125.227 38.079
202212 28.886 125.222 30.398
202303 31.001 127.348 32.079
202306 35.284 128.729 36.119
202309 49.428 129.860 50.158
202312 43.940 129.419 44.740
202403 33.271 131.776 33.271

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IDEXX Laboratories  (MEX:IDXX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


IDEXX Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (MEX:IDXX) Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.